📌 Key Takeaways
- Topic: What Is Tridymite? Structure, Formation and Properties of This Silica Polymorph
- Keywords: silica supplier Russia
- Published: 2026-11-20 12:57:29
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Pharmaceutical Grade Silica: Specifications, USP/EP Standards and Uses as an Excipient
- High Purity Silica: Purity Levels (4N–6N), Specifications and Applications
- Mesoporous silica nanoparticles (MSNs) are recognized as a prime example of nanotechnology applied in the biomedical field, owing to their readily tunable structure and composition, various surface functionalization properties, and excellent biocompatibility. Over the past two decades, researchers have developed a wide range of MSNs-based nanoplatforms through careful design and controlled preparation approaches, demonstrating their adaptability to diverse biomedical application scenarios. With the continuous breakthroughs of MSNs in the fields of biosensing, disease diagnosis and treatment, tissue engineering, etc., MSNs are steadily moving from basic research to clinical trials. In this review, we supply a detailed summary of MSNs in the biomedical field, beginning with a comprehensive overview of their expansion history. We then discuss the types of MSNs-based nanostructured architectures, along with the classification of MSNs-based nanocomposites according to the elements existed in diverse inorganic functional factors. Subsequently, we summarize the primary purposes of surface-functionalized modifications of MSNs. In the following, we examine the biomedical applications of MSNs, and highlight the MSNs-based targeted therapeutic modalities currently developed. Given the importance of clinical translation, we also summarize the progress of MSNs in clinical trials. Lastly, we take a perspective on the future direction and remaining difficulties of MSNs in the biomedical field.
- Silica for Solar Crucible: Purity Standards and Supply Considerations
- Silica Exporter Guide: Export Documents, Packaging and Shipping Terms
- Zhang, J., Luz, Z. & Goldfarb, D. EPR studies of the formation mechanism of the mesoporous materials MCM-41 and MCM-50. J. Phys. Chem. B 101, 7087-7094 (1997). Post CAS Google Scholar
- Silica Demand in 2026: Key Industries Driving Growth
- Eivazzadeh-Keihan, R. et al. Recent advances in the application of mesoporous silica-based nanomaterials for bone tissue engineering. Mater. Sci. Eng. C. 107, 110267 (2020). Piece CAS Google Scholar
What Is a Silane Coupling Agent? How It Works and How to Choose One for Silica
What is silica (SiO₂)?
silica for skincare Chen, L. et al. The toxicity of silica nanoparticles to the immune system. Nanomedicine 13, 1939-1962 (2018). Article Google Scholar
What is the difference between fumed silica and precipitated silica?
alkaline silica sol The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.
What drives silica raw material prices?
silicon dioxide covalent network
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.